ANVISA registration

QC ANTI-TG 1, 2 ADVIA CENTAUR ACS 180 SYSTEMS

Registration 10345160293. TIREOGLOBULINA (CONTROLE)

Registration details

Registration number10345160293
Application number25351163480200230
Technical nameTIREOGLOBULINA (CONTROLE)
Risk classII
Published on12/12/2002
ValidityIndefinite validity

Registration holder

Legal nameSIEMENS HEALTHCARE DIAGNÓSTICOS LTDA
CNPJ01.449.930/0001-90

Manufacturer

  • SIEMENS HEALTHCARE DIAGNOSTICS INC ESTADOS UNIDOS DA AMÉRICA

Other registrations held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAview all

FAMÍLIA CA 19-9 DILUENT

10345160005

ADVIA CENTAUR TSH

10345160012

ADVIA CENTAUR T4

10345160013

ADVIA CENTAUR T3/T4 /VB12 ANCILLARY REAGENT

10345160015

ADVIA CENTAUR FT3

10345160017

ADVIA CENTAUR T3

10345160018

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist